CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Operating expenses
Research and development	$ 13,038	$ 10,470	$ 44,204	$ 39,836
General and administrative	7,168	5,491	21,778	15,652
Total operating expenses	20,206	15,961	65,982	55,488
Loss from operations	(20,206)	(15,961)	(65,982)	(55,488)
Other income (expense), net
Other income (expense), net	416	(290)	226	(611)
Total other income (expense), net	416	(290)	226	(611)
Net loss	(19,790)	(16,251)	(65,756)	(56,099)
Comprehensive loss	$ (19,790)	$ (16,251)	$ (65,756)	$ (56,099)
Net loss per share, basic (in dollars per share)	$ (0.72)	$ (21.27)	$ (2.40)	$ (76.18)
Net loss per share, diluted (in dollars per share)	$ (0.72)	$ (21.27)	$ (2.40)	$ (76.18)
Weighted average common shares outstanding, basic (in shares)	27,399,906	763,869	27,384,085	736,416
Weighted average common shares outstanding, diluted (in shares)	27,399,906	763,869	27,384,085	736,416